Go Pro
→ Man who Predicted Trump 2016 Win: “Prepare for Mid-Term Meltdown” (From Paradigm Press) (Ad)tc pixel Free FBIOP Stock Alerts

Fortress Biotech (FBIOP) Competitors

Fortress Biotech logo
$18.68 -0.04 (-0.19%)
As of 02:57 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

FBIOP vs. AIMDW, ALVOW, ARAV, ACABW, and BFRIW

Should you buy Fortress Biotech stock or one of its competitors? MarketBeat compares Fortress Biotech with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Fortress Biotech include Ainos (AIMDW), Alvotech (ALVOW), Aravive (ARAV), Atlantic Coastal Acquisition Corp. II (ACABW), and Biofrontera (BFRIW). These companies are all part of the "pharmaceutical products" industry.

How does Fortress Biotech compare to Ainos?

Fortress Biotech (NASDAQ:FBIOP) and Ainos (NASDAQ:AIMDW) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, dividends, institutional ownership, profitability, valuation, analyst recommendations, media sentiment and risk.

Company Net Margins Return on Equity Return on Assets
Fortress BiotechN/A N/A N/A
Ainos N/A N/A N/A

In the previous week, Fortress Biotech had 1 more articles in the media than Ainos. MarketBeat recorded 1 mentions for Fortress Biotech and 0 mentions for Ainos. Fortress Biotech's average media sentiment score of 0.00 equaled Ainos'average media sentiment score.

Company Overall Sentiment
Fortress Biotech Neutral
Ainos Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Fortress Biotech$66.16MN/AN/AN/AN/A
Ainos$18.11KN/AN/AN/AN/A

Summary

Fortress Biotech beats Ainos on 2 of the 2 factors compared between the two stocks.

How does Fortress Biotech compare to Alvotech?

Fortress Biotech (NASDAQ:FBIOP) and Alvotech (NASDAQ:ALVOW) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, institutional ownership, dividends, analyst recommendations, valuation, earnings and media sentiment.

In the previous week, Fortress Biotech had 1 more articles in the media than Alvotech. MarketBeat recorded 1 mentions for Fortress Biotech and 0 mentions for Alvotech. Fortress Biotech's average media sentiment score of 0.00 equaled Alvotech'saverage media sentiment score.

Company Overall Sentiment
Fortress Biotech Neutral
Alvotech Neutral

Company Net Margins Return on Equity Return on Assets
Fortress BiotechN/A N/A N/A
Alvotech N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Fortress Biotech$66.16MN/AN/AN/AN/A
Alvotech$559.42MN/AN/AN/AN/A

Summary

Fortress Biotech and Alvotech tied by winning 1 of the 2 factors compared between the two stocks.

How does Fortress Biotech compare to Aravive?

Aravive (NASDAQ:ARAV) and Fortress Biotech (NASDAQ:FBIOP) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, valuation, risk, dividends, institutional ownership, media sentiment, analyst recommendations and earnings.

Company Net Margins Return on Equity Return on Assets
AraviveN/A N/A N/A
Fortress Biotech N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AraviveN/AN/AN/A-$0.90N/A
Fortress Biotech$66.16MN/AN/AN/AN/A

In the previous week, Fortress Biotech had 1 more articles in the media than Aravive. MarketBeat recorded 1 mentions for Fortress Biotech and 0 mentions for Aravive. Aravive's average media sentiment score of 0.00 equaled Fortress Biotech'saverage media sentiment score.

Company Overall Sentiment
Aravive Neutral
Fortress Biotech Neutral

35.8% of Aravive shares are owned by institutional investors. 60.4% of Aravive shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

Aravive and Fortress Biotech tied by winning 2 of the 4 factors compared between the two stocks.

How does Fortress Biotech compare to Atlantic Coastal Acquisition Corp. II?

Atlantic Coastal Acquisition Corp. II (NASDAQ:ACABW) and Fortress Biotech (NASDAQ:FBIOP) are both pharmaceutical products companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, profitability, institutional ownership, valuation, dividends, risk, media sentiment and earnings.

Company Net Margins Return on Equity Return on Assets
Atlantic Coastal Acquisition Corp. IIN/A N/A N/A
Fortress Biotech N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Atlantic Coastal Acquisition Corp. IIN/AN/AN/AN/AN/A
Fortress Biotech$66.16MN/AN/AN/AN/A

In the previous week, Fortress Biotech had 1 more articles in the media than Atlantic Coastal Acquisition Corp. II. MarketBeat recorded 1 mentions for Fortress Biotech and 0 mentions for Atlantic Coastal Acquisition Corp. II. Atlantic Coastal Acquisition Corp. II's average media sentiment score of 0.00 equaled Fortress Biotech'saverage media sentiment score.

Company Overall Sentiment
Atlantic Coastal Acquisition Corp. II Neutral
Fortress Biotech Neutral

Summary

Fortress Biotech beats Atlantic Coastal Acquisition Corp. II on 2 of the 2 factors compared between the two stocks.

How does Fortress Biotech compare to Biofrontera?

Biofrontera (NASDAQ:BFRIW) and Fortress Biotech (NASDAQ:FBIOP) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, risk, valuation, earnings, dividends, institutional ownership, profitability and analyst recommendations.

Company Net Margins Return on Equity Return on Assets
BiofronteraN/A N/A N/A
Fortress Biotech N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Biofrontera$43.20MN/AN/AN/AN/A
Fortress Biotech$66.16MN/AN/AN/AN/A

In the previous week, Fortress Biotech had 1 more articles in the media than Biofrontera. MarketBeat recorded 1 mentions for Fortress Biotech and 0 mentions for Biofrontera. Biofrontera's average media sentiment score of 0.00 equaled Fortress Biotech'saverage media sentiment score.

Company Overall Sentiment
Biofrontera Neutral
Fortress Biotech Neutral

Summary

Fortress Biotech beats Biofrontera on 2 of the 2 factors compared between the two stocks.

Get Fortress Biotech News Delivered to You Automatically

Sign up to receive the latest news and ratings for FBIOP and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding FBIOP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

FBIOP vs. The Competition

Export
MetricFortress BiotechBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$515.96M$6.80B$12.31B
Dividend Yield12.11%3.90%2.67%9.36%
P/E RatioN/A3.1627.1624.03
Price / SalesN/A6,313.88573.71113.02
Price / CashN/A13.1329.0548.09
Price / BookN/A89.5410.676.16
Net IncomeN/A-$96.07M$3.59B$331.63M
7 Day Performance-0.13%-0.71%-1.46%-1.53%
1 Month Performance-6.90%1.13%1.20%-1.24%
1 Year Performance135.20%55.83%24.36%17.49%

Fortress Biotech Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
FBIOP
Fortress Biotech
N/A$18.68
-0.2%		N/A+135.6%$0.00$66.16MN/A170
AIMDW
Ainos
N/A$0.13
-13.3%		N/A-28.6%$0.00$18.11KN/A40
ALVOW
Alvotech
N/A$0.18
flat		N/AN/A$0.00$559.42MN/A4
ARAV
Aravive
N/A$0.04
flat		N/AN/A$0.00N/AN/A20
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.00
flat		N/AN/A$0.00N/AN/A15

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:FBIOP) was last updated on 7/20/2026 by MarketBeat.com Staff.
From Our Partners
SMX: From Under-the-Radar to Must-Watch!
SMX (Security Matters) PLC is building Digital Material Passport technology that embeds molecular-level marker...
Smallcaps Daily | Sponsoredtc pixel
Your book is inside
The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...
Profits Run | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
#1 Power Grid Stock Right Now
The U.S. power grid is cracking - and one company's technology is already generating round-the-clock power in ...
Altimetry | Sponsoredtc pixel
Your withdrawal order could cost you in taxes
If you have $2M or more saved, the 4% rule points to roughly $92,000 a year - but it's a single-variable answe...
SmartAsset | Sponsoredtc pixel
They proved it worked in '76. Then buried it.
In 1976, Chevron tapped an energy source with no fuel costs, no carbon, and no supply chain - then killed the ...
Behind the Markets | Sponsoredtc pixel
BlackRock is hoarding it. JPMorgan is hoarding it. Do you own it?
BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...
Awesomely | Sponsoredtc pixel